Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Ann Thorac Surg. 2020 Sep 16;111(5):1465–1471. doi: 10.1016/j.athoracsur.2020.06.120

Table 4.

Cox Proportional Hazards Model Results of Post Transplant Survival, January 2005 – June 2019

    95% Confidence Interval  
Predictor Hazard Ratio Lower Upper p-value
HIV positive recipient 0.94 0.53 1.65 0.820
Donor age (per 5 years) 1.06 1.05 1.07 <0.001
Recipient age        
 <45 (per 5 years) 0.91 0.89 0.93 <0.001
 >45 (per 5 years) 1.20 1.16 1.24 <0.001
Recipient male sex 0.96 0.91 1.02 0.181
Recipient ethnicity (reference: White)        
 Black 1.32 1.24 1.40 <0.001
 Hispanic 1.00 0.91 1.10 0.995
 Other 0.96 0.85 1.09 0.550
Donor/recipient sex mismatch 1.05 0.98 1.13 0.147
Recipient heart failure etiology (reference: ischemic)        
 Non-ischemic dilated 0.79 0.75 0.84 <0.001
 Other 0.98 0.89 1.02 0.13
Recipient diabetes 1.27 1.20 1.33 <0.001
Recipient durable LVAD support 1.07 1.01 1.14 0.016
Recipient ECMO support 1.95 1.61 2.37 <0.001
Recipient temporary VAD support 1.21 1.00 1.45 0.048
Recipient IABP support 1.06 0.98 1.16 0.161
Recipient prior cardiac surgery 1.13 1.07 1.19 <0.001
Graft ischemic time (per hour) 1.08 1.06 1.11 <0.001
Transplant era (reference: 2005–2009)        
 2010–2014 0.85 0.78 0.88 <0.001
 2015–2019 0.82 0.77 0.89 <0.001
Transplant center annualized volume        
 <20 (per 5 transplants) 0.93 0.90 0.96 <0.001
 >20 (per 5 transplants) 1.07 1.04 1.11 <0.001
LVAD, left ventricular assist device; ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device; IABP, intra-aortic balloon pump